$700m injury payout headed to Zyprexa users

Share this article:
A federal judge approved Eli Lilly’s largest-ever settlement: $700 million to be split among patients who took antipsychotic Zyprexa, their lawyers and federal health programs, The Indianapolis Star reported. Judge Jack Weinstein, of federal court in Brooklyn, NY, approved the terms of the liability settlement, but the amount could expand. Hundreds more have filed claims against Lilly since the settlement was announced in 2005, according to The Star. So far, more than 8,000 plaintiffs, many of them mentally ill, are included. They will receive payments after attorneys, Medicare and Medicaid get their cut. More than 60% of claimants were Medicaid beneficiaries, and some states reportedly could claim up to 30% of each award from people who have health coverage through the state-run plans. After taking Zyprexa, Lilly’s top seller, the patients claimed that the drug caused diabetes-related symptoms, including weight gain and high blood-sugar levels.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.